Importance of the Neutrophil-to-lymphocyte Ratio in Muscle-invasive and Non-muscle Invasive Bladder Tumors
Overview
Authors
Affiliations
Introduction: To research the importance of the neutrophil-to-lymphocyte ratio (NLR) in muscle-invasive bladder cancers (MIBC) and non-muscle invasive bladder cancer (NMIBC).
Methods: Data of 198 patients who underwent TUR-TM in our clinic were retrospectively evaluated. Patients were divided into two groups: group-I (MIBC) and group-II (NMIBC). The neutrophil and lymphocyte counts, NLR, hemoglobin and hematocrit values, tumor numbers, sizes and degrees of patients were recorded. Within the inter-group comparison, Mann-Whitney U test was used for the values stated with measuring, whereas a Chi-square test was used for the values stated with counting. The cut-off value for the NLR was determined with ROC curve.
Results: The NLR values of group-I and group-II were found as 4.14 ± 2.76 and 3.36 ± 2.88, respectively (p = 0.03). Whether the NLR carries a differential property was evaluated with ROC curve. The cut-off value was estimated as 3.96 according to the Youden index. With this value, sensitivity was found as 50%, specificity was 22.8% and AUC was 0.615 (p = 0.03).
Discussion: According to the data in this study, it can be said that Ta-T1 tumors are likely to be invasive by 50% if the NLR value is greater than 3.96.
Identifying novel biomarkers associated with bladder cancer treatment outcomes.
Castaneda P, Theodorescu D, Rosser C, Ahdoot M Front Oncol. 2023; 13:1114203.
PMID: 37064102 PMC: 10090444. DOI: 10.3389/fonc.2023.1114203.
Zhang Q, Lai Q, Wang S, Meng Q, Mo Z Cancer Manag Res. 2021; 13:849-860.
PMID: 33542658 PMC: 7853415. DOI: 10.2147/CMAR.S289986.
Efiloglu O, Basok B, Turan T, Toprak T, Erol B, Caskurlu T Turk J Urol. 2020; 46(3):206-212.
PMID: 32053096 PMC: 7219974. DOI: 10.5152/tud.2020.19186.
Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi P Int Braz J Urol. 2019; 45(2):315-324.
PMID: 30785697 PMC: 6541147. DOI: 10.1590/S1677-5538.IBJU.2018.0249.
Cimen H, Halis F, Saglam H, Gokce A Int Braz J Urol. 2017; 43(1):67-72.
PMID: 28124528 PMC: 5293385. DOI: 10.1590/S1677-5538.IBJU.2016.0158.